Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register May 26, 2026. Document 2026-10379. Updated Nov. 10, 2026.
- What it does
The Drug Enforcement Administration (DEA) proposes to revoke the exempted status for certain nonnarcotic prescription products that are currently on DEA's Table of Exempted Prescription Products list but whose National Drug Code (NDC) is inactive because they are no longer available and/or the company that applied for the exemption no longer exists. If finalized, these products would be removed from DEA's Table of Exempted Prescription Products list, and they would no longer be considered exempt prescription products under the Controlled Substances Act. This action will not impact exempted prescription products with active NDC numbers.
The Drug Enforcement Administration's summary, as published in the Federal Register.
- What it would change
1 part of Title 21 of the Code of Federal Regulations:
- Before this
No earlier Federal Register document under regulation identifier 1117-ZA08 since Jan. 1, 2025.
Since then:
- What happens next and when
Comments must be submitted electronically or postmarked on or before June 25, 2026.
The agency's dates, word for word.
The record as published
| Document number | 2026-10379 |
|---|---|
| Action | Notice of proposed rulemaking. |
| Agencies | Justice Department; Drug Enforcement Administration |
| Published | May 26, 2026 |
| Comments close | June 25, 2026 |
| Regulation identifier (RIN) | 1117-ZA08 |
| Docket | DEA-2026-0893 |
Source: the Federal Register (public domain). The document in the Federal Register